XTRA:AFXMedical Equipment
Assessing Carl Zeiss Meditec (XTRA:AFX) Valuation After The ZEISS Crossbeam 750 FIB SEM Launch
ZEISS parent Carl Zeiss Meditec (XTRA:AFX) has drawn fresh attention after unveiling the ZEISS Crossbeam 750 FIB SEM, a high precision system aimed at semiconductor, nanofabrication, and materials science workflows.
See our latest analysis for Carl Zeiss Meditec.
While the ZEISS Crossbeam 750 launch has coincided with a 9.82% 1 month share price return and a 4.43% 7 day share price return, the 1 year total shareholder return of 50.70% and 5 year total shareholder return of 81.22% suggest that...